PMEF
LLY icon

Point72 Middle East FZE’s Eli Lilly LLY Stock Holding History

Point72 Middle East FZE’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,900
Closed -$24.4M – 759
2023
Q4 		$24.4M Buy
41,900
+700
+2% +$409K 0.72% 11
2023
Q3 		$22.1M Buy
41,200
+39,700
+2,647% +$20.5M 0.72% 18
2023
Q2 		$703K Sell
1,500
-8,300
-85% -$3.48M 0.02% 679
2023
Q1 		$3.37M Buy
9,800
+9,100
+1,300% +$3.07M 0.11% 226
2022
Q4 		$256K Buy
+700
New +$248K 0.01% 954

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Middle East FZE's LLY Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 16,924 shares — an estimated $9.87M sold.

Point72 Middle East FZE first reported a position in LLY in Q2 2023 and held it in 2 quarters. The position peaked at $9.87M in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 16,924 Eli Lilly shares in Q1 2024, an estimated $9.87M.
  • Point72 Middle East FZE first reported a position in Eli Lilly in Q2 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Eli Lilly position peaked at $9.87M in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.